the vaccine development goals of the Global Alliance for Vaccines and
Immunization (GAVI), the International AIDS Vaccine Initiative, the DHHS
Blueprint for TB Vaccine Development, and the Malaria Vaccine Initiative.
Over the next 5 years, CDC will work with public and private partners
to help develop:
- A multistage
vaccine against malaria, as part of the Malaria Vaccine Initiative,
funded by the Bill and Melinda Gates Children's Vaccine Program
- A DNA-based
vaccine against HIV/AIDS, in collaboration with the Emory Vaccine Center
in Atlanta, Georgia
vaccines against dengue and dengue hemorrhagic fever, in collaboration
with Mahidol University in Salaya, Nakhonpathom, Thailand
vaccines against meningococcal meningitis group A, in collaboration
with WHO and the Bill and Melinda Gates Children's Vaccine Program
- An Ebola
vaccine, in collaboration with NIH
generation vaccines against Streptococcus pneumoniae using proteins
common to all pneumococcal serotypes. (Second generation conjugate vaccines
are currently under evaluation [see Box 18].)
CDC vaccine researcher working in a biosafety
level 4 (BSL-4) containment facility.
laboratories are used for work on infectious agents for which
there are no current vaccines or treatments (e.g., Ebola virus).